Renaissance Technologies’s Inozyme Pharma INZY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.88M | Sell |
470,500
-93,954
| -17% | -$376K | ﹤0.01% | 2147 |
|
|
2025
Q1 | $514K | Buy |
564,454
+143,055
| +34% | +$130K | ﹤0.01% | 2734 |
|
|
2024
Q4 | $1.17M | Buy |
421,399
+256,599
| +156% | +$711K | ﹤0.01% | 2409 |
|
|
2024
Q3 | $862K | Sell |
164,800
-23,039
| -12% | -$120K | ﹤0.01% | 2538 |
|
|
2024
Q2 | $838K | Buy |
187,839
+14,139
| +8% | +$63.1K | ﹤0.01% | 2421 |
|
|
2024
Q1 | $1.33M | Sell |
173,700
-44,800
| -21% | -$343K | ﹤0.01% | 2303 |
|
|
2023
Q4 | $931K | Sell |
218,500
-77,108
| -26% | -$329K | ﹤0.01% | 2449 |
|
|
2023
Q3 | $1.24M | Buy |
295,608
+56,408
| +24% | +$237K | ﹤0.01% | 2154 |
|
|
2023
Q2 | $1.33M | Buy |
239,200
+53,100
| +29% | +$296K | ﹤0.01% | 2273 |
|
|
2023
Q1 | $1.07M | Sell |
186,100
-72,800
| -28% | -$417K | ﹤0.01% | 2441 |
|
|
2022
Q4 | $272K | Buy |
258,900
+103,500
| +67% | +$109K | ﹤0.01% | 3268 |
|
|
2022
Q3 | $416K | Buy |
155,400
+37,100
| +31% | +$99.3K | ﹤0.01% | 3034 |
|
|
2022
Q2 | $564K | Buy |
118,300
+106,400
| +894% | +$507K | ﹤0.01% | 3091 |
|
|
2022
Q1 | $49K | Buy |
+11,900
| New | +$49K | ﹤0.01% | 3916 |
|